Thioredoxin, oxidative stress, cancer and aging by Lisa C Flores et al.
Flores et al. Longevity & Healthspan 2012, 1:4
http://www.longevityandhealthspan.com/content/1/1/4REVIEW Open AccessThioredoxin, oxidative stress, cancer and aging
Lisa C Flores1, Melanie Ortiz1, Sara Dube1, Gene B Hubbard1,2, Shuko Lee4, Adam Salmon1,3,5, Yiqiang Zhang1
and Yuji Ikeno1,2,4,5*Abstract
The Free Radical or Oxidative Stress Theory of Aging is one of the most popular theories in aging research and has
been extensively studied over the past several decades. However, recent evidence using transgenic/knockout mice
that overexpress or down-regulate antioxidant enzymes challenge the veracity of this theory since the animals
show no increase or decrease in lifespan. These results seriously call into question the role of oxidative damage/
stress in the aging process in mammals. Therefore, the theory requires significant modifications if we are to
understand the relationship between aging and the regulation of oxidative stress. Our laboratory has been
examining the impacts of thioredoxins (Trxs), in the cytosol and mitochondria, on aging and age-related diseases.
Our data from mice that are either up-regulating or down-regulating Trx in different cellular compartments, that is,
the cytosol or mitochondria, could shed some light on the role of oxidative stress and its pathophysiological
effects. The results generated from our lab and others may indicate that: 1) changes in oxidative stress and the
redox state in the cytosol, mitochondria or nucleus might play different roles in the aging process; 2) the role of
oxidative stress and redox state could have different pathophysiological consequences in different tissues/cells, for
example, mitotic vs. post-mitotic; 3) oxidative stress could have different pathophysiological impacts in young and
old animals; and 4) the pathophysiological roles of oxidative stress and redox state could be controlled through
changes in redox-sensitive signaling, which could have more diverse effects on pathophysiology than the
accumulation of oxidative damage to various molecules. To critically test the role of oxidative stress on aging and
age-related diseases, further study is required using animal models that regulate oxidative stress levels differently in
each cellular compartment, each tissue/organ, and/or at different stages of life (young, middle and old) to change
redox sensitive signaling pathways.
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Oxidative stress theory of aging
The Free Radical or Oxidative Stress Theory of Aging is
one of the most popular theories in aging research and
has been extensively studied over the past several dec-
ades. This theory is based on the fact that cells exist in a
chronic state of oxidative stress resulting from an imbal-
ance between pro-oxidants and antioxidants. Because of
this imbalance, which occurs as a consequence of aer-
obic metabolism, it is proposed that an accumulation of
oxidative damage occurs with age in a variety of macro-
molecules within the cell. This steady state of increased* Correspondence: ikeno@uthscsa.edu
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reproduction in any medium, provided the oroxidative damage is proposed to be an important factor
in the age-related increase in pathology and the progres-
sive decline in the functional efficiency of various cellu-
lar processes [1-3].
One consistent line of evidence to support the oxida-
tive stress hypothesis of aging is the large amount of
data that has shown an age-related increase of oxidative
damage in a variety of molecules (lipids, proteins and
DNA) in organisms ranging from invertebrates to
humans [1,4-10]. Another strong line of evidence comes
from manipulation studies that increase lifespan. Calorie
restriction (CR), which extends lifespan and delays aging
in various species, has been shown to reduce the level of
oxidative damage in tissues as measured by a decrease in
lipofuscin [11-13], lipid peroxidation [13-18], protein
oxidation [10,19-23] and DNA oxidation [24-26]. Subse-
quently, CR mice have also been shown to be moretd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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IGF-1 signaling pathways (age-1, daf-2, and daf-16
mutants) of Caenorhabditis elegans showed an increase
in lifespan, which was also correlated with increased re-
sistance to oxidative stress [27] and reduced oxidative
damage [28]. More recently, several genetic mouse mod-
els of longevity have been reported, for example, Ames
and Snell dwarf mice, p66sch−/− mice, and Igf1r+/− female
mice [29], and the increased lifespan in these models has
been correlated to increased resistance to oxidative stress
[30]. Thus, the observations that experimental manipula-
tions that increase lifespan in rodents and invertebrates
are correlated to increased resistance to oxidative stress or
reduced oxidative damage have provided strong evidence
in support of the oxidative stress theory of aging. How-
ever, all the experimental manipulations that increase life-
span also alter processes beyond oxidative stress/damage;
therefore, the increased longevity in these animal models
could arise through other mechanisms. A recent study
using naked mole-rats, which have a lifespan approaching
30 years, showed an increased amount of oxidative dam-
age compared to the short-lived mouse [31] and calls into
question the role of oxidative damage in aging.
Transgenic (TG)/knockout (KO) animal models for the free
radical/oxidative stress theory of aging
Transgenic/knockout animals provide investigators with
a unique system for studying the underlying mechanisms
of various biological processes and have been used to
conduct numerous studies to test the various theories of
aging. The most direct test of the oxidative stress hy-
pothesis of aging is to alter the accumulation of oxida-
tive damage and determine its effect on aging/lifespan.
Over the past two decades, investigators have used
Drosophila or mice with genetic alterations in the antioxi-
dant defense system as a strategy to alter the age-related
accumulation of oxidative damage. Data from these stud-
ies have the potential to establish a causative role for oxi-
dative stress/damage in aging. However, studies between
Drosophila and mice have shown inconsistent results, rais-
ing the possibility that differences in species might affect
the outcome of a genetic manipulation on lifespan.
Drosophila
In the initial studies using P-element mediated trans-
formation, researchers introduced either Cu/Zn super-
oxide dismutase (SOD) [32-34] or catalase [35] into
Drosophila; the survival of the resulting flies was not sig-
nificantly different from their wild-type controls. Subse-
quently, Orr and Sohal [36] reported that overexpression
of both Cu/ZnSOD and catalase significantly increased
(from 14 to 34%) maximum lifespan and increased the
mortality rate doubling time from 20% to 37%. Addition-
ally, these transgenic lines of Drosophila had significantlylower levels of protein and DNA oxidation [36,37]. How-
ever, these studies are complicated because the placement
of P-elements has been shown to alter lifespan independ-
ently [38,39]. Using a combined total of over 90,000 flies
to minimize the problem of P-element insertion, Orr et al.
[40] found that the overexpression of both Cu/ZnSOD
and catalase had no beneficial effects on survivorship and
was in fact associated with slightly decreased lifespans in
long-lived Drosophila strains. Investigators have also used
inducible systems to overexpress antioxidant genes in
Drosophila to circumvent the problem of P-element inser-
tion. These studies have shown that overexpression of Cu/
ZnSOD or MnSOD increased the lifespan of Drosophila,
but overexpression of catalase had no benefit [41,42].
Parkes et al. [43] showed that the induced overexpression
of Cu/ZnSOD selectively targeted to motor neurons
resulted in a 40% increase in lifespan in Drosophila and
increased resistance to oxidative stress. Two groups stud-
ied the effect of inducing the overexpression of methio-
nine sulfoxide reductase A (MsrA), which repairs oxidized
methionine, in Drosophila. Chavous et al. [44,45] showed
that overexpressing MsrA 3- to 7-fold resulted in a 32% to
39% extension in lifespan, while Ruan et al. [46] showed
that the overexpression of MsrA in the nervous system of
Drosophila increased the fly’s lifespan and resistance to
oxidative stress.
Mice
Several groups have genetically altered various compo-
nents of the antioxidant defense system in mice. In
1987, Epstein’s laboratory produced a transgenic mouse
that overexpressed human Cu/ZnSOD 1.6- to 6-fold
in various tissues [47]. These transgenic mice were
more resistant to cerebral ischemia [48,49], but their
lifespan was the same as the wild-type mice [50]. Sur-
vival studies with various transgenic mice have also
shown negative results. Our group has conducted sur-
vival studies using mice that overexpress Cu/ZnSOD,
MnSOD, catalase (in peroxisomes), Cu/ZnSOD and
MnSOD, and Cu/ZnSOD and catalase; these trans-
genic mice were not observed to have an increased
lifespan compared to their wild-type littermates [51].
On the other hand, transgenic mice that overex-
pressed catalase in mitochondria showed an increase
in lifespan, which was associated with reduced oxida-
tive damage [52]. In contrast, Shriner et al. [52] and
Richardson’s laboratory showed that the overexpres-
sion of catalase in the cytosol (peroxisomes) did not
significantly increase lifespan. Therefore, overexpres-
sion of antioxidant enzymes does not appear to in-
crease the lifespan of mice, except for the study by
Schriner et al. [52], which indicates that altering the
antioxidant defense system in mitochondria may be
more important than in the cytosol.
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under-expressing antioxidant enzymes on aging.
Our group has studied the effect of reduced expression
of MnSOD on aging and pathology using mice heterozy-
gous for the Sod2 gene (Sod2+/− mice). The Sod2+/− mice
showed higher levels of DNA oxidation and a higher in-
cidence of cancer. However, there was no difference in
the lifespan between the Sod2+/− and wild-type mice
[53]. Cu/ZnSOD null mice, which lack Cu/ZnSOD, were
shown to have a shorter lifespan compared to the wild-
type control mice [54]. The short lifespan of these
knockout mice (in the C57BL/6 background) appears to
be due to a high incidence (approximately 90%) of hepa-
tocellular carcinoma, which was not observed in wild-
type mice in the C57BL/6 genetic background. Our re-
cent studies demonstrated that the survival curves of
mice that were deficient in Glutathione peroxidase 1
(GPX1) and MnSOD (including genotypes: Gpx1−/−,
Sod2+/−, Gpx1+/− x Sod2+/−, Gpx1−/− x Sod2+/−) are es-
sentially the same as wild-type mice. These results are
also inconsistent with the oxidative stress theory of
aging.
Lethality (either by developmental defects or increased
uncommon cancers) by the complete absence of some
antioxidant enzymes strongly suggests the essential roles
antioxidant enzymes play in maintaining cellular and
physiological homeostasis in the body. However, based
on the data obtained from transgenic and knockout
mice, the changing oxidative damage levels by altera-
tions of major antioxidant enzymes does not seem to
have a significant impact on lifespan. More importantly,
the study by Schriner et al. [52] suggests that changes in
oxidative stress and the redox state in different cellular
compartments, that is, the cytosol or mitochondria,
might play different roles in the aging process. Addition-
ally, the mitochondria are a major source of reactive
oxygen species (ROS) and substantial evidence suggests
that ROS could play important roles in altering cellular
signaling pathways [55-57], which could have a more
significant impact on aging than the accumulation of
oxidative damage.
Thioredoxin and biological functions
Thioredoxin (Trx) was first recognized in the early
1960s as the reductant for a variety of enzymes. Trx is a
small protein (12 kDa) with two redox-active cysteine
residues in the active center (Cys-Gly-Pro-Cys) and it
has been shown to be reduced by Trx reductase in a
NADPH-dependent reaction. In its dithiol form, Trx
serves as the reductant for methionine sulfoxide (MetO)
and PAPS (3′-phosphoadenosine-5′-phosphosulfate) in
yeast and ribonucleotides in Escherichia coli [58,59]. Iso-
forms of Trx have been found in E. coli, yeast and mam-
mals. Two Trxs have been identified in humans, onecytosolic (TRX1) [60] and one mitochondrial (TRX2)
[61]. A major role of Trx is as a hydrogen donor for
enzymes involved in reductive reactions, for example,
ribonucleotide reductase, which reduces ribonucleotides
to deoxyribonucleotides for DNA synthesis; peroxire-
doxin (Prx), which reduces peroxides [62-64]; and MetO
reductase, which reduces methionine sulfoxide in pro-
teins and provides protection against oxidative stress
[65-67]. All Trxs catalyze the reduction of disulfides in
proteins more efficiently (orders of magnitude faster)
than Glutathione (GSH) or dithiothreitol [68]. Therefore,
Trx plays an important role in maintaining a reduced
environment in the cells through thiol-disulfide ex-
change reactions and protects cells and tissues from oxi-
dative stress [69]. Trx also plays a major role in thiol-
disulfide exchange reactions, which maintains cysteine
residues in a reduced state in proteins [68]. Because the
thiol-disulfide exchange reaction is rapid and readily re-
versible, this reaction is ideally suited to control protein
function via the redox state. This is particularly import-
ant for several transcription factors, such as activator
protein 1 (AP-1) and nuclear factor κB (NFκB), which
contain cysteine residues [70]. The reduction of cysteine
residues increases the DNA binding activity of these
transcription factors [71,72], which subsequently induces
the expression of target genes. In addition, Trxs have es-
sential roles in the development of mammals because
knockout mice null for either Trx1 or Trx2 are embryoni-
cally lethal [73,74]. Furthermore, Trx1 has anti-apoptotic
effects by binding to apoptosis signal-regulating kinases
(ASK) [75].
Transgenic mice overexpressing Trx1 by β-actin and
endogenous promoters
In 1999, Yodoi and colleagues generated transgenic mice
overexpressing Trx1 with a transgene containing the
human TRX1 cDNA fused to the β–actin promoter (Tg
(act-TRX1)+/0) [69]; they showed that these mice had an
extended lifespan compared to their wild-type litter-
mates [76,77]. Our study demonstrated that young and
adult mice overexpressing Trx1 had increased resistance
to oxidative stress and reduced oxidative damage to pro-
teins and lipids [78]. These results are very exciting for
the following reasons: 1) the Tg(act-TRX1)+/0 mice are
the second mouse model (the first one is mCAT mice)
to support the oxidative stress theory of aging; and 2)
these results could indicate the importance of redox
state maintenance by Trx during aging. However, the
survival study by Yodoi and colleagues has several pos-
sible deficits: 1) the study was conducted under conven-
tional housing conditions, in which the infectious status
of these mice could have potentially changed their nor-
mal aging process; and 2) the lifespan of the wild-type
C57BL/6 mice in the colony was shorter than the
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ample, the median lifespan was approximately 23 months
of age, which is much shorter than the median lifespan
of C57BL/6 mice in the aging colonies in San Antonio
(29 to 30 months of age). To examine the effects of
increased levels of Trx1 on oxidative stress in vivo and
its long-term pathophysiological consequences under op-
timal housing conditions, we have conducted an aging
study with Tg(act-TRX1)+/0 mice [78]. We observed a sig-
nificant increase in the survival of male Tg(act-TRX1)+/0
mice compared to the wild-type mice only during the
first half of their lifespan. For example, the transgenic
mice had a 25% increase in their lifespan in the earlier
part of life (75% survival) and a 13% increase in lifespan
in the median part of life (50% survival). However, the
transgenic mice showed only a 5.5% increase in lifespan
in the later part of life (25% survival) and no increase
thereafter (10% survival), which was associated with
reduced Trx1 overexpression. To further confirm our
initial observation, we conducted another survival study
using males and females. The male Tg(act-TRX1)+/0 mice
showed a significant increase in lifespan in the very early
part of life (90% survival; both cohorts), and only the first
male cohort showed a significant increase in lifespan in
the early part of life (75% survival) compared to the wild-
type mice. However, we found no difference in the life-
span at the median (50%) and the later part of life (25%,
and 10% survival) between Tg(act-TRX1)+/0 and wild-
type mice in two male cohorts. Although the Tg(act-
TRX1)+/0 female mice seemed to have an extended life-
span in the earlier part of life (75% survival) compared to
wild-type mice, none of the survival parameters were sta-
tistically significant [78]. These survival results are par-
tially consistent with the previous study by Yodoi and
colleagues that showed that the overexpression of Trx1
significantly increases median and maximum lifespans
[76,77]. Differences in results between this and previous
studies could be due to different housing conditions of
the mouse colony; the mice in our colony showed about
a 20% longer (40 months) maximum longevity than mice
maintained under conventional housing conditions (ap-
proximately 32 months) [77]. Therefore, our survival
data did show that overexpression of Trx1 increased only
the earlier part of lifespan in males, but no extension was
observed in maximum lifespan, which is a question that
remains to be answered, that is, why did Trx1 overex-
pression show an extension of lifespan only in the earlier
part of life? These mice were generated with a β-actin
promoter to drive the expression of the transgene, which
could cause an age-related decrease in the overexpres-
sion of the transgene. We observed that the levels of
overexpression significantly decreased with age, which
was correlated with less reduction in protein oxidation
levels [78].To test if continuous overexpression of Trx1 extends
maximum lifespan, we generated an additional line of
Trx1 transgenic mice (Trx1Tg) using a fragment of the
human genome containing the TRX1 gene (a BAC clone
(RP11-427 L11), Children’s Hospital Oakland Research
Institute’s (CHORI) BACPAC Resources Center (BPRC),
Oakland, CA.) with 8.3 kb and 12.3 kb of the 5′- and 3′-
flanking sequences, respectively. We have confirmed that
the transgenes in these mice were stably integrated and
successfully passed to progeny following the Mendelian
ratio for all lines of transgenic mice. We also confirmed
that the levels of Trx1 were significantly higher (approxi-
mately 20% to 40%) in all the tissues we examined in the
Trx1Tg mice, compared to their wild-type littermates,
and were similar to the levels of overexpression in the
young (4 to 6 months old) Tg(act-TRX1)+/0 mice. Fur-
thermore, overexpression of Trx1 was maintained (up to
28 to 30 months old), that is, the levels of overexpressed
Trx1 did not show any decrease or increase during
aging. There were no compensatory changes in the levels
of Trx2, glutaredoxin, glutathione or other major anti-
oxidant enzymes. A survival study with Trx1Tg and
wild-type mice was conducted and is currently ongoing.
The current survival rate of Trx1Tg and wild-type mice
is 29.8% and 27.6%, respectively. The earlier parts (75%
survival) of lifespan in Trx1Tg and wild-type mice are
707 and 665 days, respectively. The difference (6.3%) is
not significant (P> 0.05) as determined by the General-
ized Wilcoxon test. Mortality rate after 700 days appears
to be higher in the Trx1Tg than wild-type mice and no
life-extension is currently observed. Therefore, continu-
ous overexpression of Trx1 in mice showed similar
effects observed in the Tg(act-TRX1)+/0 mice, that is,
Trx1 overexpression showed some benefits for lifespan
only in the earlier part of life.
A possible explanation for these results is that Trx1
could have deleterious effects in older animals because
of its anti-apoptotic effect by inhibiting the Apoptosis
Signal-Regulating Kinase-1 (ASK1) pathway [75,79]. Our
data showed that Tg(act-TRX1)+/0 mice had higher
levels of the ASK1/Trx1 complex and reduced c-Jun N-
terminal Kinase (JNK) activation [78]. The major cause of
death in these mice was neoplastic disease, especially
lymphoma, which is consistent with the end-of-life path-
ology data from C57BL/6 mice [80]. Interestingly, the
end-of-life pathology data showed that Tg(act-TRX1)+/0
mice had higher incidences of total fatal tumors and
fatal lymphoma compared to wild-type mice. This is not
a surprising observation because Trx1 has anti-
apoptotic action by inhibiting ASK, promoting cell pro-
liferation, and is overexpressed in various cancers, in-
cluding lymphoma [60,81]. The possible role of Trx1 in
tumor development was further confirmed by our study
using the brain tumor model, which also showed that
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proliferation and reduced cell death in tumors and
tumor development (incidence and growth of tumors)
[82].
Thus, our studies show that the overexpression of
Trx1 in mice had some benefits in the earlier part of
lifespan, but did not extend maximum lifespan, possibly
due to the higher incidence of fatal tumors compared to
wild-type mice. Experimental research on all animals
was approved by the Institutional Animal Care and Use
Committee (IACUC) of the Department of Veterans
Affairs and the University of Texas Health Science Cen-
ter at San Antonio.
Oxidative stress theory of aging – future directions of
thioredoxins
Although the Free Radical or Oxidative Stress Theory of
Aging is generally accepted as an important component
of aging and age-related diseases, recent evidence using
transgenic/knockout mice overexpressing or down-
regulating antioxidant enzymes challenge the veracity of
this theory since the animals showed no increase or de-
crease in lifespan. These results seriously call into ques-
tion the role of oxidative damage/stress in the aging
process in mammals. Thus, significant modifications to
the theory are required if we are to understand the rela-
tionship between aging and the regulation of oxidative
stress. Our laboratory made the interesting observation
that the overexpression of Trx1 showed benefits only in
the earlier part of life, with an increased incidence of
tumors with age. These results led us to the following
questions: 1) why did Trx1 overexpression show some
beneficial effects on lifespan, while the overexpression of
most other antioxidants failed to extend lifespan; and 2)
why did Trx1 overexpression show an extension of life-
span only in the earlier part of life?
Several studies demonstrated that the cellular
redox state plays an important role in the physio-
logical responses to oxidative stress and aging. We
demonstrated that lifespan extension in the earlier part of
life in Tg(act-TRX1)+/0 mice is correlated to increased
levels of the Trx1 redox state. The enhanced Trx1 redox
state could play an important role in an organism’s ability
to better respond to stress by altering the signaling path-
ways that are dependent on the cellular redox state [83].
The mRNA levels of IL-1β, one of the representative tar-
get genes in the NFkB pathway, were significantly
lower in the liver tissue from Tg(act-TRX1)+/0 mice
compared to wild-type mice. There is some indication
that IL-1β could be involved in the wide-spread sys-
temic inflammatory process. Substantial evidence sug-
gests inflammation plays an important role in aging
and, additionally, Tg(act-TRX1)+/0 mice showed signifi-
cantly less incidence of inflammatory lesions in the lung(acidophilic macrophage pneumonia) compared to wild-
type mice, which occurred mainly in the earlier part of life.
Therefore, the reduction in systemic inflammation and
suppression of acidophilic macrophage pneumonia, which
is a non-neoplastic fatal disease commonly seen in
C57BL/6 mice, could be possible contributing factors for
the extension of lifespan in the earlier part of life in
the Tg(act-TRX1)+/0 mice. These observations are further
confirmed by our most recent study, in which we found
that the overexpression of Trx1 can prevent the induction
of pro-inflammatory cytokine TNFα in adipose tissue
associated with high fat feeding [84]. This reduction of in-
flammation was associated with preserved glucose toler-
ance in this model, suggesting that Trx1 prevents insulin
resistance through its anti-inflammatory effects. Together,
these findings show that Trx1-mediated regulation of the
inflammatory state may be a significant regulator of health
under various age-related pathophysiological conditions.
The next question is: why does Trx1 overexpression
show an extension of lifespan only in the earlier part of
life? As described above, we believe that the loss in life
extension, or accelerated mortality, in old Trx1 trans-
genic mice could arise because the overexpression of the
TRX1 gene could promote tumor growth, including
lymphoma, a major fatal disease in C57BL/6 mice. Trx1
could promote the development of cancer in older ani-
mals because of its anti-apoptotic effect by inhibiting the
ASK1 pathway and protecting against various stressors
[75,78,79]. The Tg(act-TRX1)+/0 mice had higher levels
of the ASK1/Trx1 complex, reduced JNK activation,
reduced oxidative damage to lipids and proteins, and
had a higher incidence of total fatal tumors and fatal
lymphoma compared to wild-type mice. Since Trx1 is
overexpressed in various cancers [81] and apoptosis
plays important roles in carcinogenesis, overexpression
of Trx1 could promote cancer growth by its anti-
apoptotic action, protection against oxidative stress, and
have deleterious effects in older animals.
Based on the data from Trx1 transgenic mice and other
mice that have either up-regulated or down-regulated vari-
ous antioxidant enzymes, it is clear that the role of oxida-
tive stress in aging seems to be more complex than the
oxidative stress theory describes. The effects of Trx1 over-
expression (and oxidative stress) could be different between
young and old mice. The protection against oxidative stress
and changes in redox-sensitive signaling, for example, in-
flammatory signaling pathways, by Trx1 could be beneficial
in young animals. However, our study has also indicated
that reduced oxidative stress and changes in redox-sensitive
signaling, for example, apoptosis signaling pathways, by
Trx1 could play important roles in cancer growth, which
has more deleterious effects in older animals.
Redox change in different cellular compartments is an-
other important factor to be considered when studying the
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ate most of the endogenous ROS, overexpressing Trx in
mitochondria (Trx2) could show more significant effects
on oxidative stress and longevity. Although Trx1 overex-
pression reduced the oxidative damage to proteins and
lipids, DNA oxidation was not reduced by Trx1, which
could be another reason why Trx transgenic mice had an
increased incidence of cancer. This possibility could be sup-
ported by a recent study by Schriner et al. [52] which
reported that the overexpression of catalase in mitochon-
dria significantly extended lifespan and reduced the inci-
dence of some cancers in mice, which is the only mouse
model to support the oxidative stress theory of aging. In
addition, Widder et al. [85] found beneficial roles of over-
expressing Trx in the mitochondria (TghTrx2 mice) on the
development of vascular dysfunction and hypertension,
which are common age-related pathological changes in
humans. Another study also showed the beneficial effects
of Trx2 overexpression on endothelial functions and pro-
tection against atherosclerosis development [86]. There-
fore, it is of interest to examine if overexpression of Trx2
could attenuate aging and/or age-related pathology in
mice. Another important cellular compartment is the nu-
cleus where an elegant study done by Go et al. [87]
demonstrated that transgenic mice overexpressing Trx1 in
the nucleus (NLS-hTrx1Tg) had an increased mortality by
influenza H1N1, which was associated with increased in-
flammatory signaling. These results are contrary to the
work with Trx1 (cytosolic) and Trx2 transgenic mice that
showed protection against various stresses [86,88]. This is
additional evidence supporting the notion that compart-
mentalized redox regulation is a key component of redox
signaling and cellular functions [87]. Therefore, the
changes in redox state in different compartments of cells,
that is, the mitochondria, cytosol and nucleus, could con-
trol the activity of redox-sensitive signaling in cells
differently.
These results can potentially provide two interesting sce-
narios regarding Trx, cancer and aging: 1) overexpressing
Trx in the mitochondria could play a more important role
on lifespan than in the cytosol, which is similar to the
results of the mCAT mice studies (overexpressing catalase
in the mitochondria increased lifespan, but overexpressing
catalase in the nucleus or the cytosol had no effect); and 2)
down-regulating Trx in the cytosol could play important
roles in suppressing cancer development, which may have
beneficial effects in older animals. These paradoxical, but
intriguing, scenarios could indicate that changes in the
redox state in the cytosol and mitochondria attenuate life-
span through different mechanisms, for example, protec-
tion of the mitochondria against oxidative stress and
reduced age-related pathology, such as cancer.
Based on these ideas, we are currently examining the
effects of overexpressing Trx2 and/or down-regulatingTrx1 on oxidative stress, redox status, redox-sensitive
signaling, age-related diseases (especially cancer), and
aging using Trx2 transgenic (Tg) and Trx1 knockout
(KO) mice. Our ongoing study showed Trx2Tg mice that
overexpress Trx2 in all tissues during aging showed less
ROS production in mitochondria, less oxidative stress,
and had a slight extension of lifespan in the earlier part
of life. When we test the effects of reduced levels of
thioredoxin in cytosol or mitochondria on aging, we
may observe the reverse effects, that is, life-extension
and reduction of cancer in the Trx1KO mice, while the
Trx2KO mice showed little effects on lifespan but
showed impaired mitochondrial function [89,90]. We are
also testing if overexpressing Trx2 along with down-
regulating Trx1 could show additive anti-aging effects by
using mice that up-regulate Trx in the mitochondria and
down-regulate Trx in the cytosol (Trx2Tg x Trx1KO
mice). The results from this study will allow us to deter-
mine if overexpression of Trx in the mitochondria and
down-regulation of Trx in the cytosol throughout life
play important roles in aging and age-related pathology
through common or independent pathways.
Based on our current preliminary data, we predict that
overexpressing Trx2 will provide protection against
oxidative stress in the mitochondria and delay aging,
down-regulating Trx1 will provide protection against
tumorigenesis by enhanced apoptosis or reduced cell
proliferation to delay aging, and overexpression of
Trx2 combined with down-regulation of Trx1 will
show a greater anti-aging effect and reduction of
pathology than overexpression of Trx2 or down-
regulation of Trx1 would alone.
Conclusions
Although the Free Radical or Oxidative Stress Theory of
Aging has been one of the most popular theories in
aging research over the past several decades, the results
generated from our lab and others have raised more
questions about the oxidative stress theory than pro-
vided answers. These results seriously call into question
the role of oxidative damage/stress in the aging process
in mammals, requiring us to make significant modifica-
tions to the theory of oxidative stress in aging in order
to understand the relationship between aging and the
regulation of oxidative stress. The results generated from
our lab (Trx1Tg, Trx1KO, Trx2Tg) and others (for ex-
ample, mCAT mice, NLS-hTrx1Tg mice and TghTrx2
mice) could suggest that: 1) changes in oxidative stress
and redox state in the cytosol, mitochondria or nucleus
might play different roles in the aging process and in
age-related diseases; 2) the role of oxidative stress and
redox state could have different pathophysiological con-
sequences in different tissues/cells, for example, mitotic
vs. post-mitotic; 3) oxidative stress could have different
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4) the pathophysiological roles of oxidative stress and
redox state could be controlled through changes in redox-
sensitive signaling, which could have more diverse effects
on pathophysiology than the accumulation of oxidative
damage to various molecules. To critically test the role of
oxidative stress on aging and age-related diseases, further
study is required using animal models that regulate oxida-
tive stress levels differently in each cellular compartment,
each tissue/organ, and/or at different stages of life (young,
middle, and old) to change redox sensitive signaling
pathways.
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